NEW YORK, Jan 5 – Senomyx has licensed Incyte's gene sequence databases to discover genes involved in taste, olfaction, and the detection of pheromones, the companies said Friday.
Under the terms of the multi-year agreement, Senomyx will have access to Incyte's LifeSeq Gold gene sequence database, ZooSeq animal model database, and bioinformatics capabilities.
Senomyx will also be able to hold exclusive licenses on certain Incyte gene patents for the commercialization of flavor- and fragrance-related products, the companies said.
Financial terms were not disclosed.
The agreement marks the first use of Incyte’s technology for the consumer product market, an estimated $900 billion market that encompasses foods, beverages, personal care products, home care products, and fine fragrances.
" Leading pharmaceutical companies have been very successful in using the interaction between drug candidate molecules and human protein targets encoded in our genome to create safer and more effective drugs. Senomyx's goal is to mirror this success to create safer and more effective consumer products,” said Paul Grayson, president and CEO of Senomyx.
Based in La Jolla, Calif., Senomyx is building a technology platform to make consumer products based on recent advances in genomics and molecular biology. The company has exclusive licenses and research collaboration agreements with Kraft Foods and Aurora Biosciences, and exclusive licenses with Harvard University, Johns Hopkins University, Rockefeller University and the University of California.